Company Profiles

driven by the PitchBook Platform

Esanex

Description

Developer of an oncology drug. The company operates a drug development company focused on advancing its highly selective and orally active Hsp90 inhibitors for treatment of cancer.

2011

Founded

PRIVATE

Status

Series A

Latest Deal Type

$15.5M

Latest Deal Amount

$15.5M

Total Amount Raised

3

Investors

Description

Developer of an oncology drug. The company operates a drug development company focused on advancing its highly selective and orally active Hsp90 inhibitors for treatment of cancer.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Primary Office

115 West Washington Street Suite 1680, South Tower Indianapolis, IN 46204United States +1 (317) 651-4272
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Esanex's full profile, request a free trial.

    Esanex Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Esanex Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Esanex Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BioCrossroadsVenture CapitalMinority000 0000000 0000
    Intersouth PartnersVenture CapitalMinority000 0000000 0000
    Lilly VenturesCorporate Venture CapitalMinority000 0000000 0000
    BioCrossroads Venture Capital
    Intersouth Partners Venture Capital
    Lilly Ventures Corporate Venture Capital

    Esanex Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Everardus Orlemans Ph.DChief Scientific Officer & Senior Vice President, Development
    Everardus Orlemans Ph.D Chief Scientific Officer & Senior Vice President, Development

    Esanex Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Richard MillerSelfBoard Member000 0000
    Steven Hall Ph.DLilly VenturesGeneral Partner000 0000
    Richard Miller Board Member Self
    Steven Hall Ph.D General Partner Lilly Ventures
    Request full access to PitchBook